Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.8M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
2.62M
-
Shares change
-
+346K
-
Total reported value, excl. options
-
$18.9M
-
Value change
-
+$2.67M
-
Number of buys
-
9
-
Number of sells
-
-5
-
Price
-
$7.20
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q4 2019
17 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q4 2019.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.62M shares
of 26.8M outstanding shares and own 9.77% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (1.47M shares), AWM Investment Company, Inc. (517K shares), VANGUARD GROUP INC (282K shares), PRELUDE CAPITAL MANAGEMENT, LLC (128K shares), BlackRock Inc. (73.8K shares), ROYAL BANK OF CANADA (64.2K shares), Centric Wealth Management (28K shares), FIRST TRUST ADVISORS LP (24.2K shares), NORTHERN TRUST CORP (21.4K shares), and WELLS FARGO & COMPANY/MN (6K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.